The European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the French pharmaceutical giant said on Wednesday.
Jul 3, 2024
0
0
A new study sheds light on the critical role of patient education in managing cardiovascular diseases. Researchers examined the information needs of over 1,600 heart patients from diverse regions, revealing significant insights ...
Jul 3, 2024
0
0
With the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this population are growing yet often poorly understood and addressed.
Jul 3, 2024
0
0
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published in JAMA Network Open by leaders from Nemours Children's Health and Endeavor ...
Jul 3, 2024
0
4
A new artificial intelligence (AI) tool that can help physicians to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU).
Jul 3, 2024
0
48
At the beginning of the COVID-19 pandemic, a group of Brazilian researchers showed why SARS-CoV-2 infection tends to be more severe in diabetic patients. Now, the same team based at the Institute of Biology of the State University ...
Jul 2, 2024
0
2
A novel approach for early cancer treatment known as radioligand therapy (RLT) has been shown to significantly reduce the risk of advanced neuroendocrine tumor progression and death, according to research led by scientists ...
Jul 2, 2024
0
73
A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday.
Jul 2, 2024
0
2
Artificial intelligence (AI), machine learning (ML), and deep learning (DL) are increasingly transforming the medical field by enhancing diagnostic accuracy, prognostic predictions, precision treatments, and operational efficiency ...
Jul 2, 2024
0
1
Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published online July 1 in JAMA Network Open.
Jul 2, 2024
0
0
